Evidence map›Paper›PMID 42033020›Full record

ArticleChembiochem : a European journal of chemical biology2026

How to Enhance the Applicability of Metal Ion Affinity-bound Biocatalysts? Comprehensive Overview and Case Study With a Phenylalanine Ammonia Lyase and an Amine Transaminase.

Máté Laurinyecz, Bálint Alács, Zsófia Molnár, Laura Edit Barabás, Beáta G Vértessy, Csaba Paizs, László Poppe, Evelin Bell

Abstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Máté LaurinyeczDepartment of Organic Chemistry and Technology, Faculty of Chemical Technology and Biotechnology, Budapest University of Technology and Economics, Budapest, Hungary.
Bálint AlácsDepartment of Organic Chemistry and Technology, Faculty of Chemical Technology and Biotechnology, Budapest University of Technology and Economics, Budapest, Hungary.
Zsófia MolnárDepartment of Organic Chemistry and Technology, Faculty of Chemical Technology and Biotechnology, Budapest University of Technology and Economics, Budapest, Hungary.
Laura Edit BarabásEnzymology and Applied Biocatalysis Research Centre, Faculty of Chemistry and Chemical Engineering, Babeş-Bolyai University of Cluj-Napoca, Cluj-Napoca, Romania.ORCID 0000-0002-3599-9753
Beáta G VértessyHUN-REN Research Centre for Natural Sciences, Institute of Molecular Life Sciences, Budapest, Hungary.ORCID 0000-0002-1288-2982
Csaba PaizsEnzymology and Applied Biocatalysis Research Centre, Faculty of Chemistry and Chemical Engineering, Babeş-Bolyai University of Cluj-Napoca, Cluj-Napoca, Romania.ORCID 0000-0002-7403-7098
László PoppeDepartment of Organic Chemistry and Technology, Faculty of Chemical Technology and Biotechnology, Budapest University of Technology and Economics, Budapest, Hungary.ORCID 0000-0002-8358-1378
Evelin BellDepartment of Organic Chemistry and Technology, Faculty of Chemical Technology and Biotechnology, Budapest University of Technology and Economics, Budapest, Hungary.ORCID 0000-0002-9083-7757

Funding

National Recovery and Resilience Plan for Romania cod PNRR-C9-I8-CF 87/31.07.2023National Recovery and Resilience Plan for Romania no. 760241/28.12.2023Nemzeti Kutatási, Fejlesztési és Innovaciós Alap 2022-1.2.2-TÉT-IPARI-UZ-2022-00003Nemzeti Kutatási, Fejlesztési és Innovaciós Alap FK137867Nemzeti Kutatási, Fejlesztési és Innovaciós Alap K135231Nemzeti Kutatási, Fejlesztési és Innovaciós Alap K146890Nemzeti Kutatási, Fejlesztési és Innovaciós Alap NKP-2018-1.2.1-NKP-2018-00005Nemzeti Kutatási, Fejlesztési és Innovaciós Alap RRF-2.3.1-21-2022-00015Nemzeti Kutatási, Fejlesztési és Innovaciós Alap SNN-146370Nemzeti Kutatási, Fejlesztési és Innovaciós Alap TKP2021-EGA-02
6 · The paper itself

Abstract

Selective metal ion affinity binding as a simple and renewable enzyme immobilization was investigated using the same affinity function on various supports. Phenylalanine ammonia-lyase from parsley (PcPAL) and an amine transaminase from Vibrio fluvialis (VfTA) with His-tag were used as model enzymes. Metal ion chelating groups on the surface of six enzyme carriers were created from the surface-alkylamino moieties by treatment with ethylenediaminetetraacetic dianhydride and subsequent complexation with cobalt(II) ions. Three porous polymer beads, two silica-based supports, and a silica-coated magnetic nanoparticle (MNP) were investigated as carriers. The most effective PcPAL biocatalyst forms were tested in kinetic resolution and ammonia addition reactions with substrates containing phenyl and thiophen-2-yl rings. In the selective ammonia addition reaction onto the (hetero)arylacrylates needing a harsh medium of a 6 M ammonia solution, the biocatalysts exhibited excellent stability and led to l-amino acids in high yield and excellent enantiomeric excess. The recharging of the MNP supports was investigated by five subsequent cycles of reactions-after elution with 5% diethylenetriamine and reloading with fresh PcPAL or VfTA-retaining over 80% of the relative activities until the third cycle. The repurposing of the supports was also investigated by changing one enzyme to the other on the MNP-immobilized metal ion affinity chromatography support.

Indexed as

CobaltEnzymes, ImmobilizedPhenylalanine Ammonia-LyaseTransaminasesBiocatalysisKineticsSilicon DioxideVibrioCobaltEnzymes, ImmobilizedPhenylalanine Ammonia-LyaseSilicon DioxideTransaminasesamine transaminaseenzyme carrierenzyme immobilizationmetal ion affinity bindingphenylalanine ammonia‐lyase

Identifiers

PMID42033020
PMCPMC13109676

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.